SERES THERAPEUTICS INC (MCRB)
US81750R1023 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 144.9M 336.45% | 7.1M -95.10% | 126.325M 1,679.23% | -100.00% | 14.994M | 19.699M 31.38% | 63.75M 223.62% | -100.00% | 527.78M | 556.32M 5.41% | |
| EBITDA YoY % growth | -58.55M 28.18% | -239.87M -309.68% | -101.74M 57.59% | -119.09M -17.05% | -120.262M -0.98% | -58.168M 51.63% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -64.5M 26.79% | -246.5M -282.17% | -107.983M 56.19% | -129.854M -20.25% | -87.205M 32.84% | -90.636M -3.94% | -56.14M 38.06% | -119.34M -112.58% | 391.25M 427.84% | 447.1M 14.27% | |
| Operating Margin | -44.51% | -3,471.83% | -85.48% | N/A | -581.60% | -460.11% | -88.06% | N/A | 74.13% | 80.37% | |
| EPS YoY % growth | -0.72 37.39% | -2.34 -225.00% | -0.90 61.54% | -0.73 18.78% | -0.57 22.67% | -0.44 22.86% | -0.63 -45.03% | 3.60 669.35% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 38.10% | -0.16 39.68% | -0.16 25.51% | -0.17 56.16% | -0.18 10.92% |
| Revenue Q2Q % growth | -100.00% | ||||
| EBITDA Q2Q % growth | -36.72M -10.33% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.602M 37.76% | -25.041M 31.05% | -26.316M 16.04% | -27.285M 6.46% | -28.713M -16.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.38 -2.70% | -0.25 | -0.13 | -51.81% |
| Q2 2024 Q2Q % growth | -0.22 -161.11% | -0.28 | 0.06 | 21.28% |
| Q1 2024 Q2Q % growth | -0.27 52.63% | -0.35 | 0.08 | 22.33% |
| Q4 2023 Q2Q % growth | -0.32 40.74% | -0.51 | 0.19 | 36.89% |
| Q3 2023 Q2Q % growth | -0.37 24.49% | -0.51 | 0.14 | 27.66% |
| Q2 2023 Q2Q % growth | 0.36 151.43% | 0.54 | -0.18 | -33.89% |
| Q1 2023 Q2Q % growth | -0.57 6.56% | -0.56 | -0.01 | -1.81% |
| Q4 2022 Q2Q % growth | -0.54 -3.85% | -0.47 | -0.07 | -13.85% |
| Q3 2022 Q2Q % growth | -0.49 -168.06% | -0.48 | -0.01 | -2.48% |
| Q2 2022 Q2Q % growth | -0.70 -32.08% | -0.61 | -0.09 | -15.12% |
| Q1 2022 Q2Q % growth | -0.61 -56.41% | -0.53 | -0.08 | -14.08% |
| Q4 2021 Q2Q % growth | -0.52 -126.09% | -0.45 | -0.07 | -16.75% |
| Q3 2021 Q2Q % growth | 0.72 300.00% | -0.47 | 1.19 | 252.50% |
| Q2 2021 Q2Q % growth | -0.53 -89.29% | -0.38 | -0.15 | -39.68% |
| Q1 2021 Q2Q % growth | -0.39 -39.29% | -0.32 | -0.07 | -23.61% |
| Q4 2020 Q2Q % growth | -0.23 8.00% | -0.29 | 0.06 | 19.43% |
| Q3 2020 Q2Q % growth | -0.36 -56.52% | -0.26 | -0.10 | -38.33% |
| Q2 2020 Q2Q % growth | -0.28 -16.67% | -0.26 | -0.02 | -6.34% |
| Q1 2020 Q2Q % growth | -0.28 52.54% | -0.29 | 0.01 | 2.31% |
| Q4 2019 Q2Q % growth | -0.25 51.92% | -0.28 | 0.03 | 11.94% |
| Q3 2019 Q2Q % growth | -0.23 57.41% | -0.33 | 0.10 | 29.75% |
| Q2 2019 Q2Q % growth | -0.24 64.71% | -0.49 | 0.25 | 51.42% |
| Q1 2019 Q2Q % growth | -0.59 14.49% | -0.40 | -0.19 | -46.30% |
| Q4 2018 Q2Q % growth | -0.52 | -0.51 | -0.01 | -2.78% |
| Q3 2018 Q2Q % growth | -0.54 | -0.53 | -0.01 | -0.98% |
| Q2 2018 Q2Q % growth | -0.68 | -0.65 | -0.03 | -5.34% |
| Q1 2018 Q2Q % growth | -0.69 | -0.77 | 0.08 | 10.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | 100.00% | 255K | -255K | -100.00% |
| Q4 2023 Q2Q % growth | 64K -93.60% | 357K | -293K | -82.07% |
| Q3 2023 Q2Q % growth | 310K -90.88% | 870.06K | -560.06K | -64.37% |
| Q2 2023 Q2Q % growth | 126.473M 10,439.42% | 128.11M | -1.637M | -1.28% |
| Q1 2023 Q2Q % growth | -500K -133.33% | 1.614M | -2.114M | -130.98% |
| Q4 2022 Q2Q % growth | 1M -86.11% | 6.118M | -5.118M | -83.65% |
| Q3 2022 Q2Q % growth | 3.4M -97.32% | 7.144M | -3.744M | -52.41% |
| Q2 2022 Q2Q % growth | 1.2M -77.36% | 5.078M | -3.878M | -76.37% |
| Q1 2022 Q2Q % growth | 1.5M -73.68% | 8.649M | -7.149M | -82.66% |
| Q4 2021 Q2Q % growth | 7.2M -59.09% | 12.499M | -5.299M | -42.40% |
| Q3 2021 Q2Q % growth | 126.7M 8,950.00% | 7.462M | 119.238M | 1,597.94% |
| Q2 2021 Q2Q % growth | 5.3M -11.67% | 5.503M | -203K | -3.69% |
| Q1 2021 Q2Q % growth | 5.7M -30.49% | 6.579M | -879K | -13.36% |
| Q4 2020 Q2Q % growth | 17.6M 131.58% | 7.07M | 10.53M | 148.94% |
| Q3 2020 Q2Q % growth | 1.4M -80.00% | 7.423M | -6.023M | -81.14% |
| Q2 2020 Q2Q % growth | 6M -52.00% | 9.735M | -3.735M | -38.37% |
| Q1 2020 Q2Q % growth | 8.2M 12.33% | 8.701M | -501K | -5.76% |
| Q4 2019 Q2Q % growth | 7.6M -28.30% | 6.376M | 1.224M | 19.20% |
| Q3 2019 Q2Q % growth | 7M -23.08% | 6.833M | 167K | 2.44% |
| Q2 2019 Q2Q % growth | 12.5M 171.74% | 8.291M | 4.209M | 50.77% |
| Q1 2019 Q2Q % growth | 7.3M 82.50% | 15.619M | -8.319M | -53.26% |
| Q4 2018 Q2Q % growth | 10.6M | 13.365M | -2.765M | -20.69% |
| Q3 2018 Q2Q % growth | 9.1M | 11.593M | -2.493M | -21.50% |
| Q2 2018 Q2Q % growth | 4.6M | 6.703M | -2.103M | -31.37% |
| Q1 2018 Q2Q % growth | 4M | 2.44M | 1.56M | 63.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 17.94% | 17.94% | 23.61% | 26.25% |
| Revenue | N/A | N/A | -100% | N/A |